Market Cap 33.14B
Revenue (ttm) 3.62B
Net Income (ttm) 541.50M
EPS (ttm) N/A
PE Ratio 47.29
Forward PE 39.78
Profit Margin 14.95%
Debt to Equity Ratio 1.23
Volume 5,135,500
Avg Vol 3,711,768
Day's Range N/A - N/A
Shares Out 390.60M
Stochastic %K 85%
Beta 1.12
Analysts Strong Sell
Price Target $98.05

Latest News on DXCM

DexCom, Abbott Agree to Settlement in Patent Litigation

Dec 23, 2024, 4:56 PM EST - 25 days ago

DexCom, Abbott Agree to Settlement in Patent Litigation

ABT


Abbott and DexCom settle glucose monitor patent disputes

Dec 23, 2024, 4:17 PM EST - 25 days ago

Abbott and DexCom settle glucose monitor patent disputes

ABT


DexCom: Brighter 2025 From Stelo Ramp

Dec 10, 2024, 3:18 PM EST - 5 weeks ago

DexCom: Brighter 2025 From Stelo Ramp


DexCom Pairs Its Glucose Monitor With Oura's Smart Ring

Nov 19, 2024, 12:50 PM EST - 2 months ago

DexCom Pairs Its Glucose Monitor With Oura's Smart Ring


Oura CEO on new partnership with Dexcom

Nov 19, 2024, 7:47 AM EST - 2 months ago

Oura CEO on new partnership with Dexcom


Dexcom and ŌURA Announce Strategic Partnership

Nov 19, 2024, 6:00 AM EST - 2 months ago

Dexcom and ŌURA Announce Strategic Partnership


3 Top Stocks for Growth Investors to Buy Now

Nov 12, 2024, 12:00 PM EST - 2 months ago

3 Top Stocks for Growth Investors to Buy Now

RTO VEEV


DexCom Growing Into Its Valuation, But Still No Bargain

Oct 25, 2024, 9:00 AM EDT - 3 months ago

DexCom Growing Into Its Valuation, But Still No Bargain


DexCom, Inc. (DXCM) Q3 2024 Earnings Call Transcript

Oct 24, 2024, 7:25 PM EDT - 3 months ago

DexCom, Inc. (DXCM) Q3 2024 Earnings Call Transcript


Dexcom shares fall on slow revenue growth

Oct 24, 2024, 4:57 PM EDT - 3 months ago

Dexcom shares fall on slow revenue growth


Dexcom Reports Third Quarter 2024 Financial Results

Oct 24, 2024, 4:03 PM EDT - 3 months ago

Dexcom Reports Third Quarter 2024 Financial Results